Abstract
Invasive coronary angiography is a primary imaging modality that visualizes the lumen area of coronary arteries for the diagnosis of coronary artery diseases and guidance for interventional devices. In the current practice of quantitative coronary analysis (QCA), semi-automatic segmentation tools require labor-intensive and time-consuming manual correction; this limits their application in the catheterization room. For a more automated QCA, it is necessary to minimize operator intervention through robust segmentation methods with improved predictability. In this study, we introduced two selective ensemble methods that integrated the weighted ensemble approach with per-image quality estimation. In our selective ensemble methods, the segmentation outcomes from five base models with different loss functions were ranked by mask morphology or estimated dice similarity coefficient (DSC). The final output was determined by imposing different weights according to the ranking. The ranking criteria based on mask morphology were determined empirically to avoid frequent types of segmentation errors, whereas the estimation of DSCs was performed by comparing the pseudo-ground truth generated from a meta-learner. In the assessment with 7,426 frames from 2,924 patients, the selective ensemble methods improved segmentation performance with DSCs of up to 93.11% and provided a better delineation of lumen boundaries near the coronary lesion with local DSCs of up to 94.04%, outperforming all individual models and hard voting ensembles. The probability of mask disconnection at the most narrowed region could be minimized to <1%. The robustness of the proposed methods was evident in the external validation. Inference time for major vessel segmentation was approximately one-third, indicating that our selective ensemble methods may allow the real-time application of QCA-based diagnostic methods in routine clinical settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This material was supported by the Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No. 2020-0-00159), and by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science & ICT, the Ministry of Trade, Industry & Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: KMDF_PR_20200901_0013).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, Korea 05505 Institutional Review Board of Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon, Korea 35015
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available because the permission of sharing patient data was not granted by the Institutional Review Board but are available from the corresponding author on reasonable request.
